Steroid refractory dermatomyositis following combination dabrafenib and trametinib therapy

Stephanie Harrison, Alice Tew, Neil Steven, Benjamin Fisher

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)
99 Downloads (Pure)

Abstract

Rheumatology key message:

Autoimmune events may arise following therapy with MAPK/ERK pathway inhibitors.
Original languageEnglish
JournalRheumatology (Oxford)
Early online date30 Mar 2018
DOIs
Publication statusE-pub ahead of print - 30 Mar 2018

Fingerprint

Dive into the research topics of 'Steroid refractory dermatomyositis following combination dabrafenib and trametinib therapy'. Together they form a unique fingerprint.

Cite this